- Home
- SENEA vs TKNO Comparison
SENEA vs TKNO Comparison
Compare SENEA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- TKNO
- Stock Information
- Founded
- SENEA 1949
- TKNO 1996
- Country
- SENEA United States
- TKNO United States
- Employees
- SENEA N/A
- TKNO N/A
- Industry
- SENEA Packaged Foods
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- SENEA Consumer Staples
- TKNO Health Care
- Exchange
- SENEA Nasdaq
- TKNO Nasdaq
- Market Cap
- SENEA 520.7M
- TKNO 430.2M
- IPO Year
- SENEA N/A
- TKNO 2021
- Fundamental
- Price
- SENEA $73.33
- TKNO $8.15
- Analyst Decision
- SENEA
- TKNO Buy
- Analyst Count
- SENEA 0
- TKNO 2
- Target Price
- SENEA N/A
- TKNO $5.00
- AVG Volume (30 Days)
- SENEA 16.8K
- TKNO 324.6K
- Earning Date
- SENEA 02-06-2025
- TKNO 03-10-2025
- Dividend Yield
- SENEA N/A
- TKNO N/A
- EPS Growth
- SENEA 23.82
- TKNO N/A
- EPS
- SENEA 5.83
- TKNO N/A
- Revenue
- SENEA $1,482,656,000.00
- TKNO $36,347,000.00
- Revenue This Year
- SENEA N/A
- TKNO $3.47
- Revenue Next Year
- SENEA N/A
- TKNO $12.07
- P/E Ratio
- SENEA $12.59
- TKNO N/A
- Revenue Growth
- SENEA N/A
- TKNO N/A
- 52 Week Low
- SENEA $43.89
- TKNO $1.16
- 52 Week High
- SENEA $81.39
- TKNO $9.72
- Technical
- Relative Strength Index (RSI)
- SENEA 45.21
- TKNO 50.87
- Support Level
- SENEA $70.58
- TKNO $7.15
- Resistance Level
- SENEA $75.00
- TKNO $8.53
- Average True Range (ATR)
- SENEA 1.95
- TKNO 0.69
- MACD
- SENEA -0.66
- TKNO -0.11
- Stochastic Oscillator
- SENEA 25.44
- TKNO 43.86
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.